Crestor shines for Shionogi as antibiotics flag
This article was originally published in Scrip
Executive Summary
Helped by the contribution of the acquired Sciele business in the US, Shionogi has reported an 8% rise in its total sales, to ¥143.4 billion ($1.78 billion), in the first half ended 30 September.